Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study

被引：0

作者：

Otte, C. ^{[1
]}

Hinkelmann, K. ^{[1
]}

Moritz, S. ^{[1
]}

Yassouridis, A. ^{[2
]}

Jahn, H. ^{[1
]}

Wiedemann, K. ^{[1
]}

Kellner, M. ^{[1
]}

机构：

[1] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat, Hamburg, Germany

[2] Max Planck Inst Psychiat, D-80804 Munich, Germany

来源：

PHARMACOPSYCHIATRY | 2009年 / 42卷 / 05期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

A120

引用

页码：234 / 234

页数：1

共 50 条

[41] Memantine Add-On to Risperidone for Treatment of Negative Symptoms in Patients With Stable Schizophrenia Randomized, Double-Blind, Placebo-Controlled Study
Rezaei, Farzin
Mohammad-karimi, Maryam
Seddighi, Sahar
Modabbernia, Amirhossein
Ashrafi, Mandana
Salehi, Bahman
Hammidi, Siran
Motasami, Hamid
Hajiaghaee, Reza
Tabrizi, Mina
Akhondzadeh, Shahin
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (03) : 336 - 342
[42] Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
Koblan, Kenneth S.
Hopkins, Seth C.
Sarma, Kaushik
Jin, Fengbin
Goldman, Robert
Kollins, Scott H.
Loebel, Antony
NEUROPSYCHOPHARMACOLOGY, 2015, 40 (12) : 2745 - 2752
[43] Dasotraline for the Treatment of Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled, Proof-of-Concept Trial in Adults
Kenneth S Koblan
Seth C Hopkins
Kaushik Sarma
Fengbin Jin
Robert Goldman
Scott H Kollins
Antony Loebel
Neuropsychopharmacology, 2015, 40 : 2745 - 2752
[44] DEXAMETHASONE FOR THE TREATMENT OF DEPRESSION - A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
ARANA, GW
SANTOS, AB
LARAIA, MT
MCLEODBRYANT, S
BEALE, MD
RAMES, LJ
ROBERTS, JM
DIAS, JK
MOLLOY, M
AMERICAN JOURNAL OF PSYCHIATRY, 1995, 152 (02): : 265 - 267
[45] Topiramate add-on treatment in schizophrenia: a randomised, double-blind, placebo-controlled clinical trial
Afshar, H.
Roohafza, H.
Mousavi, G.
Golchin, S.
Toghianifar, N.
Sadeghi, M.
Talaei, M.
JOURNAL OF PSYCHOPHARMACOLOGY, 2009, 23 (02) : 157 - 162
[46] Efficacy and Safety of Lamotrigine as Add-On Treatment to Lithium in Bipolar Depression: A Multicenter, Double-Blind, Placebo-Controlled Trial
van der Loos, Marc L. M.
Mulder, Paul G. H.
Hartong, Erwin G. Th. M.
Blom, Marc B. J.
Vergouwen, Anton C.
de Keyzer, Herman J. U. E. M.
Notten, Peter J. H.
Luteijn, Marijke L.
Timmermans, Manuela A.
Nolen, Willem A.
JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (02) : 223 - 231
[47] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF FLUNARIZINE AS ADD-ON THERAPY IN EPILEPSY
OVERWEG, J
BINNIE, CD
MEIJER, JWA
MEINARDI, H
NUIJTEN, STM
SCHMALTZ, S
WAUQUIER, A
EPILEPSIA, 1984, 25 (02) : 217 - 222
[48] A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjogren's syndrome
Juarez, Maria
Diaz, Nieves
Johnston, Geoffrey, I
Nayar, Saba
Payne, Andrew
Helmer, Eric
Cain, Dionne
Williams, Paulette
Devauchelle-Pensec, Valerie
Fisher, Benjamin A.
Giacomelli, Roberto
Gottenberg, Jacques-Eric
Guggino, Giuliana
Kvarnstrom, Marika
Mariette, Xavier
Ng, Wan Fai
Rosas, Jose
Burson, Juan Sanchez
Triolo, Giovanni
Barone, Francesca
Bowman, Simon J.
RHEUMATOLOGY, 2021, 60 (03) : 1364 - 1375
[49] A Randomized, Double-Blind, Placebo-Controlled Proof-Of-Concept Study of Ondansetron for Alcohol Use Disorder in Outpatients With Bipolar and Related Disorders
Brown, E. Sherwood
McArdle, Meagan
Bice, Collette
Ivleva, Elena
Nakamura, Alyson
McNutt, Markey
Holmes, Traci
Patel, Zena
Tipton, Shane
NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 110 - 110
[50] N-Acetylcysteine in the Treatment of Pediatric Tourette Syndrome: Randomized, Double-Blind, Placebo-Controlled Add-On Trial
Bloch, Michael H.
Panza, Kaitlyn E.
Yaffa, Alisa
Alvarenga, Pedro G.
Jakubovski, Ewgeni
Mulqueen, Jilian M.
Landeros-Weisenberger, Angeli
Leckman, James F.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (04) : 327 - 334

← 1 2 3 4 5 →